0.2634

54.04% +0.0924

After Hours: .2427 -0.0207 -7.86%

Nuwellis Inc (NUWE)

Overview News Price History Financials Discussions Forecast Stock Split

Nuwellis Inc stock is currently priced at $0.2634, with a 24-hour trading volume of 134.37M. It has seen a +54.04% increased in the last 24 hours and a -29.02% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $0.167 pivot point. If it approaches the $0.2139 resistance level, significant changes may occur.

Previous Close:

$0.171

Open:

$0.32

24h Volume:

134.37M

Market Cap:

$4.01M

Revenue:

$8.86M

Net Income/Loss:

$-20.21M

P/E Ratio:

-0.00512

EPS:

-51.41

Net Cash Flow:

$-18.19M

1W Performance:

+70.60%

1M Performance:

-29.02%

6M Performance:

-60.39%

1Y Performance:

-94.16%

1D Range:

$0.24

$0.36

52W Range:

$0.125

$4.59

Nuwellis Inc Stock (NUWE) Company Profile

Name

Nuwellis Inc

Sector

Healthcare (1216)

Industry

Medical Devices (160)

Phone

952 345 4200

Address

12988 Valley View Road, Eden Prairie

Employee

Twitter

Next Earnings Date

2024-05-10

Latest SEC Filings

NUWE's Discussions on Twitter

Nuwellis Inc Stock (NUWE) Latest News

Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference

GlobeNewswire Inc.

Nuwellis Inc Stock (NUWE) Financials Data

Nuwellis Inc (NUWE) Revenue 2024

NUWE reported a revenue (TTM) of $8.86 million for the quarter ending December 31, 2023, a +3.76% rise year-over-year.

Nuwellis Inc (NUWE) Net Income 2024

NUWE net income (TTM) was -$20.21 million for the quarter ending December 31, 2023, a -39.13% decrease year-over-year.

Nuwellis Inc (NUWE) Cash Flow 2024

NUWE recorded a free cash flow (TTM) of -$18.18 million for the quarter ending December 31, 2023, a -19.08% decrease year-over-year.

Nuwellis Inc (NUWE) Earnings per Share 2024

NUWE earnings per share (TTM) was -$12.62 for the quarter ending December 31, 2023, a +89.90% growth year-over-year.

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.